terconazole has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ringdahl, EN | 1 |
| Giaquinta, D; Horowitz, BJ; Ito, S | 1 |
| Corson, SL; Kapikian, RR; Nehring, R | 1 |
| Delecour, M | 1 |
2 review(s) available for terconazole and Recrudescence
| Article | Year |
|---|---|
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
Evolving pathogens in vulvovaginal candidiasis: implications for patient care.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Nonprescription Drugs; Ointments; Recurrence; Risk Factors; Species Specificity; Suppositories; Triazoles | 1992 |
2 trial(s) available for terconazole and Recrudescence
| Article | Year |
|---|---|
Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Miconazole; Middle Aged; Recurrence; Triazoles | 1991 |
Advantages of a 6- to 7-day treatment with 40-mg vaginal suppositories of terconazole against vaginal candidosis: conclusions drawn from a phase II multicentre study in France.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Humans; Recurrence; Suppositories; Time Factors; Triazoles; Vagina | 1985 |